Janux Therapeutics (JANX) announced that William Go has been appointed chief medical officer, effective January 26. Go succeeds Zachariah McIver, who will be leaving the company to pursue other opportunities. Most recently Go served as CMO at A2 Biotherapeutics.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JANX:
- Janux Therapeutics Inks Global Oncology Collaboration With BMS
- Janux Therapeutics: Bristol Myers Collaboration Validates Tumor-Activated Platform and Enhances Risk–Reward Profile
- Janux Therapeutics enters exclusive license agreement with Bristol Myers
- Janux Therapeutics downgraded to Hold from Buy at Clear Street
- Janux Therapeutics price target lowered to $30 from $42 at Piper Sandler